Navigation Links
Successful PCR amplification and subcloning of a GC-rich DNA fragment
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Successful PCR amplification and subcloning rich DNA fragment

(Date:11/9/2009)...se is a research industry first, allowing veterina...arch safety study data to be managed in one softwa...nolls, NJ (PRWEB) November 9, 2009 -- Xybion Medic...istima™ VM, an integrated enterprise softwar...use and care of veterinary research subjects. Pris...
(Date:11/7/2009)...wire/ -- Research projects in the areas of mathema...g, as Tim Kunisky of Livingston, NJ and the team o...A received the highest honors at the Region Five F...ence & Technology, the nation,s premier high s...scom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) ,...
(Date:11/6/2009).../ -- Myriant Technologies LLC ("Myriant"), a priva...renewable bio-chemicals, Uhde Corporation of Ameri..., one of the world,s leading engineering contracto... engineering, procurement & construction (EPC)...on renewable feedstocks. The execution of this al...
(Date:11/6/2009)...Call/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:O...ed updated results from a Phase II study of intrav...atic to the lung in a poster presentation at the 1...ing held in Miami Beach, Florida, from November 5t...se II Study of Intravenous REOLYSIN (Wild-type Reo...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...isition Creates Expanded Biodefense Pipeline, ANN...x: PIP ) a biodefense company specializing in the...termeasures against biological and,chemical threat...sition of,Avecia,s biodefense vaccines business pr...ight, President and Chief Executive Officer, comme...
...2, 2008 PAREXEL International,Corporation (Nasdaq...ices,organization, today announced that Larry Eres...bouj, M.D., have been appointed as Vice Presidents...he Company,s international,clinical pharmacology b...arly phase clinical development in the central ner...
...inia and ROSH HAAYIN, Israel, April 2 The,Virgini...ntly announced the,newest company to establish the...rch Park as a member of the VBCC program, EnzySurg...c wound management., "EnzySurge has developed Der...treaming Therapy(TM) (CST) technology. DermaStream...
Other Biology Technology:PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 2PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 3PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 4PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 5PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 2PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 3PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 4PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 5EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center 2EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center 3
(Date:11/9/2009)... government and industry researchers has completed...genome. The project is an important first step in ...nce crop and addressing some of the many limitatio... Cassava is a root crop that serves as the primary... day. Although it has many properties that make it...
(Date:11/9/2009)...t responsible for the rapid, mysterious death of p...found by collaborating scientists at Rutgers Unive... (WHOI). This same chemical may hold unexpected p... a previously unknown lipid, or fatty compound, in...iania huxleyi , a phytoplankton that plays a major...
(Date:11/8/2009)...8, 2009) The loss of a gene through deletion of g...h significant abnormalities in learning and behavi... College of Medicine ( www.bcm.edu ) in a report t...netics . , "This research goes about 95 percent ... group of individuals to this gene," said Dr. Arth...
Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Developmental delay could stem from nicotinic receptor deletion 2Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies 13974 1Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies 13974 2Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 1Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 2Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 3Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 4QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4
...ences on health and disease has begun to shed ligh...rate different characteristics, such as susceptibi...nmental exposure to nutritional, chemical and phys...aning above the genome, the epigenome refers to di...thout changing the sequence of DNA. , An article...
... Board has funded Washington Universitys Internati...ainability (I-CARES) nearly $3 million for biofuel...orate with others at Saint Louis University, the U... Louis and the Donald Danforth Plant Science Cente...ablishing alternative sources of fuel as well as r...
...vices does not involve the same rigorous review us...n order to improve health outcomes, say researcher.... , The UCSF team analyzes the problem and prop...icle in the January 2008 issue of the Journal of G...al devices. UCSF researchers Mitchell D. Feldman,...
Other Biology News:Environmental epigenetics has potential for preventing and treating disease 2Environmental epigenetics has potential for preventing and treating disease 3Missouri board grants Washington University Sustainability Center $3 million 2Analysis calls for medical device information to better serve patients and doctors 2Analysis calls for medical device information to better serve patients and doctors 3
Mouse Anti-Human FACTOR I Monoclonal Antibody, Unconjugated, Clone 3R2/2 from AbD Serotec
Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH
RAPTOR from Bioinformatics Solutions Inc.
Mouse Anti-L1 Protein of Human Papilloma Virus Monoclonal Antibody, Unconjugated, Clone CAMVIR-1 from BD Biosciences Pharmingen
Biology Products: